一种用于预测HPV诱导癌症患者生存的通用[18F]-FDG PET影像组学特征
本研究利用五家机构组成的队列(包括局部晚期宫颈癌104例与90例、肛门鳞状细胞癌66例与67例、口咽鳞状细胞癌45例),从治疗前[18F]-FDG PET图像提取影像组学特征,构建机器学习模型预测无进展生存期和总生存期。基于影像组学的CoxNet模型在测试集上取得了PFS的C-index为0.75和0.78,OS的C-index为0.76、0.74和0.75,且影像组学模型性能优于生物临床模型,联合两者并未提升性能。
要点
- 基于[18F]-FDG PET的影像组学CoxNet模型在测试集上预测PFS的C-index为0.75和0.78,预测OS的C-index为0.76、0.74和0.75。
- 影像组学特征模型的性能优于生物临床变量模型,联合影像组学与生物临床变量并未提升模型性能。
- 基于代谢肿瘤体积(MTV)的模型在多数测试配置中C-index较低,但时间依赖AUC表现相当。
核心结论
- 结果表明,有可能识别出通用的基于PET的图像特征来预测HPV诱导病理患者的反应,并在多中心多构建者数据上得到验证。
研究设计与样本
- 研究使用五家机构的队列:中心1(Gustave Roussy Campus Cancer)的104例局部晚期宫颈癌患者和中心2(Leeds Teaching Hospitals NHS Trust)的90例局部晚期宫颈癌患者;中心3(Institut du Cancer de Montpellier)的66例肛门鳞状细胞癌患者和中心4(Oslo University Hospital)的67例肛门鳞状细胞癌患者;中心5(University Hospital of Zurich)的45例口咽鳞状细胞癌患者。
- 从基线[18F]-FDG PET图像提取影像组学特征,应用ComBat技术减轻扫描仪内变异。
- 对四种机器学习模型应用改进的共识嵌套交叉验证进行特征选择与超参数调优,以协调后的影像特征和/或临床与生物学变量为输入预测无进展生存期(PFS)和总生存期(OS)。
- 每个模型在中心1和中心3队列上训练与优化,并在中心2、中心4和中心5队列上测试。
主要发现
- 基于影像组学的CoxNet模型在测试集上预测PFS的C-index为0.75和0.78,预测OS的C-index为0.76、0.74和0.75。
- 基于影像组学特征的模型性能优于生物临床模型,联合影像组学与生物临床变量并未提升性能。
- 基于代谢肿瘤体积(MTV)的模型在多数测试配置中C-index较低,但时间依赖AUC(td-AUC)表现相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Locally advanced cervical cancer (LACC) and anal and oropharyngeal squamous cell carcinoma (ASCC and OPSCC) are mostly caused by oncogenic human papillomaviruses (HPV). In this paper, we developed machine learning (ML) models based on clinical, biological, and radiomic features extracted from pre-treatment fluorine-18-fluorodeoxyglucose positron emission tomography ([18F]-FDG PET) images to predict the survival of patients with HPV-induced cancers. For this purpose, cohorts from five institutions were used: two cohorts of patients treated for LACC including 104 patients from Gustave Roussy Campus Cancer (Center 1) and 90 patients from Leeds Teaching Hospitals NHS Trust (Center 2), two datasets of patients treated for ASCC composed of 66 patients from Institut du Cancer de Montpellier (Center 3) and 67 patients from Oslo University Hospital (Center 4), and one dataset of 45 OPSCC patients from the University Hospital of Zurich (Center 5). Radiomic features were extracted from baseline [18F]-FDG PET images. The ComBat technique was applied to mitigate intra-scanner variability. A modified consensus nested cross-validation for feature selection and hyperparameter tuning was applied on four ML models to predict progression-free survival (PFS) and overall survival (OS) using harmonized imaging features and/or clinical and biological variables as inputs. Each model was trained and optimized on Center 1 and Center 3 cohorts and tested on Center 2, Center 4, and Center 5 cohorts. The radiomic-based CoxNet model achieved C-index values of 0.75 and 0.78 for PFS and 0.76, 0.74, and 0.75 for OS on the test sets. Radiomic feature-based models had superior performance compared to the bioclinical ones, and combining radiomic and bioclinical variables did not improve the performances. Metabolic tumor volume (MTV)-based models obtained lower C-index values for a majority of the tested configurations but quite equivalent performance in terms of time-dependent AUCs (td-AUC). The results demonstrate the possibility of identifying common PET-based image signatures for predicting the response of patients with induced HPV pathology, validated on multi-center multiconstructor data.
引用
- Niyoteka S, Seban RD, Rouhi R, et al. A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers. Eur J Nucl Med Mol Imaging. 2023. PMID: 37632562. doi:10.1007/s00259-023-06320-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。